vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and UL Solutions Inc. (ULS). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $340.0M, roughly 2.2× UL Solutions Inc.). On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs -12.4%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -31.8%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
The UL enterprise is a global private safety company headquartered in Northbrook, Illinois, composed of three organizations, UL Research Institutes, UL Standards & Engagement and UL Solutions.
CLOV vs ULS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $749.2M | $340.0M |
| Net Profit | $27.3M | — |
| Gross Margin | — | — |
| Operating Margin | 3.6% | 24.4% |
| Net Margin | 3.6% | — |
| Revenue YoY | 62.0% | -12.4% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $749.2M | $340.0M | ||
| Q4 25 | $487.7M | $789.0M | ||
| Q3 25 | $496.6M | $783.0M | ||
| Q2 25 | $477.6M | $776.0M | ||
| Q1 25 | $462.3M | $705.0M | ||
| Q4 24 | $337.0M | $739.0M | ||
| Q3 24 | $331.0M | $731.0M | ||
| Q2 24 | $356.3M | $730.0M |
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | $67.0M | ||
| Q3 25 | $-24.4M | $100.0M | ||
| Q2 25 | $-10.6M | $91.0M | ||
| Q1 25 | $-1.3M | $67.0M | ||
| Q4 24 | $-22.1M | $81.0M | ||
| Q3 24 | $-9.2M | $88.0M | ||
| Q2 24 | $7.4M | $101.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 49.7% | ||
| Q3 25 | — | 50.3% | ||
| Q2 25 | — | 49.4% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | 47.4% | ||
| Q3 24 | 24.5% | 49.0% | ||
| Q2 24 | 30.3% | 50.1% |
| Q1 26 | 3.6% | 24.4% | ||
| Q4 25 | -10.1% | 15.0% | ||
| Q3 25 | -4.9% | 19.9% | ||
| Q2 25 | -2.2% | 17.9% | ||
| Q1 25 | -0.3% | 15.5% | ||
| Q4 24 | -6.4% | 15.6% | ||
| Q3 24 | -2.7% | 17.8% | ||
| Q2 24 | 2.0% | 17.3% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 8.5% | ||
| Q3 25 | -4.9% | 12.8% | ||
| Q2 25 | -2.2% | 11.7% | ||
| Q1 25 | -0.3% | 9.5% | ||
| Q4 24 | -6.6% | 11.0% | ||
| Q3 24 | -2.8% | 12.0% | ||
| Q2 24 | 2.1% | 13.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $0.33 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $0.45 | ||
| Q1 25 | — | $0.33 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.44 | ||
| Q2 24 | — | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $339.4M | — |
| Total Assets | $697.7M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | $295.0M | ||
| Q3 25 | — | $255.0M | ||
| Q2 25 | — | $272.0M | ||
| Q1 25 | — | $267.0M | ||
| Q4 24 | $194.5M | $298.0M | ||
| Q3 24 | $288.0M | $327.0M | ||
| Q2 24 | $254.8M | $295.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $491.0M | ||
| Q3 25 | — | $544.0M | ||
| Q2 25 | — | $608.0M | ||
| Q1 25 | — | $653.0M | ||
| Q4 24 | — | $742.0M | ||
| Q3 24 | — | $797.0M | ||
| Q2 24 | — | $810.0M |
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $1.3B | ||
| Q3 25 | $340.9M | $1.2B | ||
| Q2 25 | $344.2M | $1.1B | ||
| Q1 25 | $336.1M | $970.0M | ||
| Q4 24 | $341.1M | $904.0M | ||
| Q3 24 | $342.2M | $872.0M | ||
| Q2 24 | $324.9M | $769.0M |
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | $2.9B | ||
| Q3 25 | $559.7M | $2.9B | ||
| Q2 25 | $575.0M | $2.9B | ||
| Q1 25 | $583.7M | $2.9B | ||
| Q4 24 | $580.7M | $2.8B | ||
| Q3 24 | $653.0M | $2.9B | ||
| Q2 24 | $674.2M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.56× | ||
| Q1 25 | — | 0.67× | ||
| Q4 24 | — | 0.82× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 1.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
